2/13/2014 9:16:26 AM
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) announced today the closing of its public offering of 3,450,000 shares of its common stock, which includes 450,000 shares sold upon the full exercise of the underwriters' option to purchase additional shares, resulting in aggregate gross proceeds of $43,125,000, before underwriting discounts, commissions and expenses.
Help employers find you! Check out all the jobs and post your resume.
comments powered by